Concepedia

Lali Margvelashvili

LM

2

Publications

65

Citations

2

H-Index

2021

Active since

Affiliations

PTC Therapeutics (United States)(Current)

Lali Margvelashvili is an author at PTC Therapeutics (United States) specializing in clinical chemistry, medicine, and pharmacology.

Top concepts

Publications per year

2021–2024

2

Publications

2

PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers study

Drago Bratkovic, Lali Margvelashvili, Michel Tchan et al. · Metabolism · 2021 · 41 citations · Full text

Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial

Ania C. Muntau, Nicola Longo, Fatih Süheyl Ezgü et al. · The Lancet · 2024 · 24 citations

, , +5

Rows per page

1–2 of 2